Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1432Pancreatic Neoplasms 860Carcinoma, Hepatocellular 743Stomach Neoplasms 647Colonic Neoplasms 447Rectal Neoplasms 404Esophageal Neoplasms 398Breast Neoplasms 331Carcinoma, Non-Small-Cell Lung 326Neoplasms 307Liver Neoplasms 282Cholangiocarcinoma 244Ovarian Neoplasms 243Lung Neoplasms 237Neoplasm Metastasis 235Gastrointestinal Neoplasms 217Melanoma 185Prostatic Neoplasms 166Esophageal Squamous Cell Carcinoma 166Biliary Tract Neoplasms 161Endometrial Neoplasms 143Uterine Cervical Neoplasms 130Squamous Cell Carcinoma of Head and Neck 129Carcinoma, Renal Cell 114Head and Neck Neoplasms 113Sarcoma 100Urinary Bladder Neoplasms 97Adenocarcinoma Of Esophagus 90Triple Negative Breast Neoplasms 86Anus Neoplasms 83

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cholangitis × Gastrointestinal × 1 year × Clear all
NCT03104569 2025-12-26

Effect of 37℃ Non-ionic Contrast Agent During ERCP Procedure in Hilar Cholangiocarcinoma

Hepatopancreatobiliary Surgery Institute of Gansu Province

Phase NA Not yet recruiting
100 enrolled
Gastrointestinal

Cholangitis, Klatskin Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡